Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001769139 | SCV002003246 | uncertain significance | not provided | 2023-05-31 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in individuals with ovarian cancer (Dicks et al., 2017); This variant is associated with the following publications: (PMID: 28881617) |
Sema4, |
RCV002258307 | SCV002527317 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-08-24 | criteria provided, single submitter | curation | |
Labcorp Genetics |
RCV003772032 | SCV004681837 | uncertain significance | Fanconi anemia | 2023-07-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1313188). This variant has not been reported in the literature in individuals affected with FANCM-related conditions. This variant is present in population databases (rs764204806, gnomAD 0.02%). This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 568 of the FANCM protein (p.Ile568Thr). |